Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines
- 1 July 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (2) , 224-228
- https://doi.org/10.1038/bjc.1996.341
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell Lines in vitroEuropean Journal Of Cancer, 1995
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroBritish Journal of Cancer, 1994
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- INCREASED DNA-REPAIR AS A MECHANISM OF ACQUIRED-RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II) IN HUMAN OVARIAN-CANCER CELL-LINES1988
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975